P04587 (POL_HV1B5) Human immunodeficiency virus type 1 group M subtype B (isolate BH5)(HIV-1)

Gag-Pol polyprotein UniProtKBInterProInteractive Modelling

1447 aa; Sequence (Fasta)

Available Structures

64 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Kinetics, stability, and structural changes in high resolution crystal structures of HIV-1 protease…
2avo
 Heteromer
Q7SSI0; 		501-599
1×SO4; 1×DMS; 1×MK1; 2×ACY; 1×GOL;
Assess
HIV-1 protease complexed with gem-diol-amine tetrahedral intermediate NLLTQI
3b7v
 Heteromer
Q7SSI0; 		501-599
1×NA; 3×CL; 1×GOL;
Assess
HIV-1 protease mutant I54V complexed with gem-diol-amine intermediate NLLTQI
3b80
 Heteromer
Q7SSI0; 		501-599
1×NA; 3×CL;
Assess
Crystal structure of HIV-1 mutant I54V and inhibitor SAQUINA
3d1y
homo-2-mer501-599
1×NA; 2×CL; 1×ROC;
Assess
Crystal structure of HIV-1 mutant I54M and inhibitor saquinavir
3d1x
homo-2-mer501-599
3×CL; 1×ROC; 1×GOL;
Assess
Crystal structure of HIV-1 mutant I54V and inhibitor DARUNAVIA
3d20
homo-2-mer501-599
1×NA; 2×CL; 1×017;
Assess
kinetics, stability, and structural changes in high resolution crystal structures of HIV-1 protease…
2avs
homo-2-mer501-599
2×PO4; 1×SO4; 1×DMS; 1×MK1; 4×ACY;
Assess
Crystal structure analysis of HIV-1 protease mutant V82A with a substrate analog P2-NC
2aog
homo-2-mer501-599
1×2NC; 1×UNX; 5×GOL; 1×ACY;
Assess
Kinetics, stability, and structural changes in high resolution crystal structures of HIV-1 protease…
2avm
homo-2-mer501-599
3×GOL; 1×2NC; 1×ACY;
Assess
Combining Mutations in HIV-1 Protease to Understand Mechanisms of Resistance
1k1t
homo-2-mer501-599
1×0Q4; 1×SO4;
Assess
Crystal structure of HIV-1 mutant I50V and inhibitor saquinavira
3cyx
homo-2-mer501-599
1×ROC; 1×NA; 1×ACY; 1×GOL; 1×PO4;
Assess
HIV-1 protease mutant I50V complexed with inhibitor TMC114
2f8g
homo-2-mer501-599
1×NA; 2×CL; 2×ACY; 1×017; 1×GOL;
Assess
HIV-1 Protease mutant L90M complexed with inhibitor TMC114
2f81
homo-2-mer501-599
1×NA; 2×CL; 1×017; 2×GOL;
Assess
Kinetics, stability, and structural changes in high resolution crystal structures of HIV-1 protease…
2avq
homo-2-mer501-599
1×DMS; 2×GOL; 1×2NC;
Assess
Crystal structure of HIV-1 mutant I54M and inhibitor DARUNAVIR
3d1z
homo-2-mer501-599
3×CL; 1×017; 1×ACY;
Assess
Crystal structure analysis of HIV-1 protease mutant I84V with a substrate analog P2-NC
2aoc
homo-2-mer501-599
1×UNX; 1×NA; 3×CL; 3×DMS; 2×GOL; 1×2NC;
Assess
Crystal structure analysis of HIV-1 Protease mutant V82A with a substrate analog P1-P6
2aof
homo-2-mer501-599
1×NA; 2×CL; 1×ACY;
Assess
Effect of Flap Mutations on Structure of HIV-1 Protease and Inhibition by Saquinavir and Darunavir
3cyw
homo-2-mer501-599
5×CL; 1×017; 1×GOL;
Assess
Crystal structure analysis of HIV-1 protease with a substrate analog P1-P6
2aoi
homo-2-mer501-599
1×SO4;
Assess
Crystal structure analysis of HIV-1 protease with a substrate analog P2-NC
2aod
homo-2-mer501-599
1×DMS; 1×UNX; 1×2NC; 3×GOL;
Assess
Crystal structure analysis of HIV-1 Protease mutant V82A with a substrate analog P6-PR
2aoh
homo-2-mer501-599
1×NA; 2×CL;
Assess
HIV-1 Protease mutant D30N complexed with inhibitor TMC114
2f80
homo-2-mer501-599
2×CL; 1×SO4; 1×017;
Assess
Crystal Structure of HIV Protease complexed with N-(3-fluoro-2-(2-((2S,5S)-5-methyl-1-(phenylsulfon…
6b3f
homo-2-mer501-599
3×CL; 1×CKV;
Assess
Crystal Structure of HIV Protease complexed with N-(3-fluoro-2-(2-((2S,6R)-6-methyl-1-(phenylsulfon…
6b38
homo-2-mer501-599
3×CL; 2×CKM;
Assess
Crystal Structure of HIV Protease complexed with N-(3-fluoro-2-(2-((2S,6S)-6-methyl-1-(phenylsulfon…
6b3g
homo-2-mer501-599
3×CL; 2×CKY;
Assess
Kinetics, stability, and structural changes in high resolution crystal structures of HIV-1 protease…
2avv
homo-2-mer501-599
1×MK1; 2×ACY; 1×CL;
Assess
crystal structure analysis of HIV-1 protease mutant V82A with a substrate analog CA-P2
2aoe
homo-2-mer501-599
1×NA; 3×CL; 1×DMS; 1×ACY; 3×GOL; 1×0Q4;
Assess
Combining Mutations in HIV-1 Protease to Understand Mechanisms of Resistance
1k1u
homo-2-mer501-599
1×0Q4;
Assess
Crystal Structure of HIV Protease complexed with N-(3-fluoro-2-(2-((2S,6R)-6-methyl-1-(phenylsulfon…
6b3c
homo-2-mer501-599
3×CL; 1×CKS;
Assess
Crystal structure analysis of HIV-1 protease with a substrate analog P6-PR
2aoj
homo-2-mer501-599
2×DMS; 4×ACY; 1×GOL;
Assess
Crystal Structure of HIV Protease complexed with N-(2-(2-((6R,9S)-2,2-dioxido-2-thia-1,7-diazabicyc…
6b3h
homo-2-mer501-599
2×CN4; 4×CL;
Assess
Crystal Structure of HIV Protease complexed with (S)-N-(3-fluoro-2-(2-(1-(phenylsulfonyl)piperazin-…
6b36
homo-2-mer501-599
4×CL; 1×CKD;
Assess
STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE: HIGH RESOLUTION CRYSTAL STRUCT…
1ffi
homo-2-mer501-599
1×2NC;
Assess
Combining Mutations in HIV-1 Protease to Understand Mechanisms of Resistance
1k2b
homo-2-mer501-599
1×0Q4;
Assess
STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE: HIGH RESOLUTION CRYSTAL STRUCT…
1fej
homo-2-mer501-599
1×2NC;
Assess
HIV-1 protease in complex with a benzyl decorated oligoamine
3bgc
homo-2-mer501-599
1×LJH; 2×CL;
Assess
STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE: HIGH RESOLUTION CRYSTAL STRUCT…
1fg6
homo-2-mer501-599
1×2NC;
Assess
I50V HIV-1 protease mutant in complex with a carbamoyl decorated pyrrolidine-based inhibitor
2r3t
homo-2-mer501-599
1×CL; 1×G4G;
Assess
I84V HIV-1 protease mutant in complex with a carbamoyl decorated pyrrolidine-based inhibitor
2r38
homo-2-mer501-599
2×CL; 1×G4G;
Assess
I84V HIV-1 protease in complex with a pyrrolidine diester
3bc4
homo-2-mer501-599
4×LLG; 2×DMS;
Assess
STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE: HIGH RESOLUTION CRYSTAL STRUCT…
1ff0
homo-2-mer501-599
1×2NC;
Assess
STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE: HIGH RESOLUTION CRYSTAL STRUCT…
1fg8
homo-2-mer501-599
1×0Q4;
Assess
CRYSTAL STRUCTURE OF HIV-1 PROTEASE IN COMPLEX WITH VX-478, A POTENT AND ORALLY BIOAVAILABLE INHIBI…
1hpv
homo-2-mer501-599
1×478;
Assess
HIV-1 protease in complex with a isobutyl decorated oligoamine
3bgb
homo-2-mer501-599
1×LJG; 2×CL;
Assess
STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE: HIGH RESOLUTION CRYSTAL STRUCT…
1fgc
homo-2-mer501-599
1×2NC;
Assess
HIV-1 protease-inhibitor complex
2bpy
homo-2-mer501-599
1×3IN;
Assess
STRUCTURAL IMPLICATIONS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE : HIGH RESOLUTION CRYSTAL STRUC…
1fff
homo-2-mer501-599
1×0Q4;
Assess
HIV-1 protease-inhibitor complex
2bpv
homo-2-mer501-599
1×1IN;
Assess
I84V HIV-1 protease in complex with a amino decorated pyrrolidine-based inhibitor
2r3w
homo-2-mer501-599
1×G3G; 1×CL;
Assess
HIV-1 PROTEASE WITH CYCLIC SULFAMIDE INHIBITOR, AHA047
1g2k
homo-2-mer501-599
1×NM1;
Assess
INFLUENCE OF STEREOCHEMISTRY ON ACTIVITY AND BINDING MODES FOR C2 SYMMETRY-BASED DIOL INHIBITORS OF…
1hvj
homo-2-mer501-599
1×A78;
Assess
Combining Mutations in HIV-1 Protease to Understand Mechanisms of Resistance
1k2c
homo-2-mer501-599
1×0Q4;
Assess
STRUCTURAL BASIS OF DRUG RESISTANCE FOR THE V82A MUTANT OF HIV-1 PROTEASE: BACKBONE FLEXIBILITY AND…
1hvs
homo-2-mer501-599
1×A77;
Assess
HIV TRIPLE MUTANT PROTEASE COMPLEXED WITH INHIBITOR SB203386
1tcx
homo-2-mer501-599
1×IM1;
Assess
The Influence of I47A Mutation on Reduced Susceptibility to the Protease Inhibitor Lopinavir
2z54
homo-2-mer501-599
2×BME; 1×AB1;
Assess
HIV-1 protease-inhibitor complex
2bpz
homo-2-mer501-599
1×3IN;
Assess
HIV-1 (2:31-37, 47, 82) PROTEASE COMPLEXED WITH INHIBITOR SB203386
1bdq
homo-2-mer501-599
1×IM1;
Assess
HIV-1 protease-inhibitor complex
2bpx
homo-2-mer501-599
1×MK1;
Assess
HIV-1 (2:31-37) PROTEASE COMPLEXED WITH INHIBITOR SB203386
1bdl
homo-2-mer501-599
2×IM1;
Assess
HIV-1 (2: 31, 33-37) PROTEASE COMPLEXED WITH INHIBITOR SB203386
1bdr
homo-2-mer501-599
1×IM1;
Assess
HIV-1 protease-inhibitor complex
2bpw
homo-2-mer501-599
1×1IN;
Assess
Solution structure of the mature HIV-1 protease monomer
1q9p
monomer501-595
Assess
SOLUTION STRUCTURE OF H12C MUTANT OF THE N-TERMINAL ZN BINDING DOMAIN OF HIV-1 INTEGRASE COMPLEXED …
1wjf
monomer1160-1214
1×CD;
Assess
SOLUTION STRUCTURE OF H12C MUTANT OF THE N-TERMINAL ZN BINDING DOMAIN OF HIV-1 INTEGRASE COMPLEXED …
1wje
monomer1160-1205
1×CD;
Assess

9 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6rwm.1.Ahomo-12-mer0.751160-1431
8×ZN;75.35
Assess
6rwl.1.Bmonomer0.741160-1431
1×ZN;75.35
Assess
6rwl.1.Amonomer0.731160-1428
1×ZN;75.35
Assess
6v3k.3.Ahomo-4-mer0.731182-1436
94.36
Assess
7t15.1.Ehomo-6-mer0.72133-352
84.42
Assess
7sep.1.Ahomo-2-mer0.71603-1152
98.45
Assess
5u1c.1.Ahomo-4-mer0.701182-1428
93.98
Assess
1l6n.1.Amonomer0.682-283
96.11
Assess
7asl.1.Ahomo-18-mer0.66143-377
99.15
Assess